Logo image of BPYPP

BROOKFIELD PROPERTY PART - BPY 6 1/2 PERP (BPYPP) Stock Fundamental Analysis

USA - NASDAQ:BPYPP - BMG162491499

15.535 USD
+0.21 (+1.4%)
Last: 9/19/2025, 8:00:01 PM
15.01 USD
-0.53 (-3.38%)
After Hours: 9/12/2025, 8:00:02 PM
Fundamental Rating

2

BPYPP gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 83 industry peers in the Chemicals industry. Both the profitability and financial health of BPYPP have multiple concerns. BPYPP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year BPYPP has reported negative net income.
BPYPP had a positive operating cash flow in the past year.
In the past 5 years BPYPP reported 4 times negative net income.
Of the past 5 years BPYPP 4 years had a positive operating cash flow.
BPYPP Yearly Net Income VS EBIT VS OCF VS FCFBPYPP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B

1.2 Ratios

With a Return On Assets value of -0.40%, BPYPP perfoms like the industry average, outperforming 42.17% of the companies in the same industry.
BPYPP has a Return On Equity of -4.49%. This is in the lower half of the industry: BPYPP underperforms 63.86% of its industry peers.
The Return On Invested Capital of BPYPP (2.10%) is worse than 68.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BPYPP is below the industry average of 6.34%.
Industry RankSector Rank
ROA -0.4%
ROE -4.49%
ROIC 2.1%
ROA(3y)-0.29%
ROA(5y)-0.3%
ROE(3y)-3.87%
ROE(5y)-3.15%
ROIC(3y)3.23%
ROIC(5y)3.15%
BPYPP Yearly ROA, ROE, ROICBPYPP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

With an excellent Operating Margin value of 26.32%, BPYPP belongs to the best of the industry, outperforming 93.98% of the companies in the same industry.
In the last couple of years the Operating Margin of BPYPP has declined.
The Gross Margin of BPYPP (54.29%) is better than 96.39% of its industry peers.
In the last couple of years the Gross Margin of BPYPP has declined.
Industry RankSector Rank
OM 26.32%
PM (TTM) N/A
GM 54.29%
OM growth 3Y-4.33%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.18%
GM growth 5Y-4.52%
BPYPP Yearly Profit, Operating, Gross MarginsBPYPP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

BPYPP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BPYPP has more shares outstanding
Compared to 5 years ago, BPYPP has less shares outstanding
Compared to 1 year ago, BPYPP has an improved debt to assets ratio.
BPYPP Yearly Shares OutstandingBPYPP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
BPYPP Yearly Total Debt VS Total AssetsBPYPP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

A Debt/Equity ratio of 3.95 is on the high side and indicates that BPYPP has dependencies on debt financing.
BPYPP's Debt to Equity ratio of 3.95 is on the low side compared to the rest of the industry. BPYPP is outperformed by 89.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.95
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.38
WACC5.52%
BPYPP Yearly LT Debt VS Equity VS FCFBPYPP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B

2.3 Liquidity

BPYPP has a Current Ratio of 0.20. This is a bad value and indicates that BPYPP is not financially healthy enough and could expect problems in meeting its short term obligations.
BPYPP's Current ratio of 0.20 is on the low side compared to the rest of the industry. BPYPP is outperformed by 97.59% of its industry peers.
BPYPP has a Quick Ratio of 0.20. This is a bad value and indicates that BPYPP is not financially healthy enough and could expect problems in meeting its short term obligations.
BPYPP has a Quick ratio of 0.19. This is amonst the worse of the industry: BPYPP underperforms 97.59% of its industry peers.
Industry RankSector Rank
Current Ratio 0.2
Quick Ratio 0.19
BPYPP Yearly Current Assets VS Current LiabilitesBPYPP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.94% over the past year.
The Revenue for BPYPP has decreased by -18.01% in the past year. This is quite bad
Measured over the past years, BPYPP shows a small growth in Revenue. The Revenue has been growing by 2.12% on average per year.
EPS 1Y (TTM)25.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.18%
Revenue 1Y (TTM)-18.01%
Revenue growth 3Y8.67%
Revenue growth 5Y2.12%
Sales Q2Q%-25.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BPYPP Yearly Revenue VS EstimatesBPYPP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
BPYPP Yearly EPS VS EstimatesBPYPP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 0 1 -1 2 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BPYPP. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BPYPP Price Earnings VS Forward Price EarningsBPYPP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BPYPP is valued a bit more expensive than 71.08% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 21.52
BPYPP Per share dataBPYPP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 -500 1K -1K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

BPYPP has a Yearly Dividend Yield of 10.64%, which is a nice return.
Compared to an average industry Dividend Yield of 3.47, BPYPP pays a better dividend. On top of this BPYPP pays more dividend than 96.39% of the companies listed in the same industry.
BPYPP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 10.64%

5.2 History

The dividend of BPYPP has a limited annual growth rate of 1.64%.
BPYPP has been paying a dividend for over 5 years, so it has already some track record.
As BPYPP did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)1.64%
Div Incr Years0
Div Non Decr Years5
BPYPP Yearly Dividends per shareBPYPP Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of BPYPP are negative and hence is the payout ratio. BPYPP will probably not be able to sustain this dividend level.
DP-126.6%
EPS Next 2YN/A
EPS Next 3YN/A
BPYPP Yearly Income VS Free CF VS DividendBPYPP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B

More info and screens

BROOKFIELD PROPERTY PART - BPY 6 1/2 PERP

NASDAQ:BPYPP (9/19/2025, 8:00:01 PM)

After market: 15.01 -0.53 (-3.38%)

15.535

+0.21 (+1.4%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners16.39%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap114.34M
Analysts46.67
Price TargetN/A
Short Float %0.35%
Short Ratio1.36
Dividend
Industry RankSector Rank
Dividend Yield 10.64%
Yearly Dividend1.48
Dividend Growth(5Y)1.64%
DP-126.6%
Div Incr Years0
Div Non Decr Years5
Ex-Date09-02 2025-09-02 (0.40625)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.35
P/B 0.01
P/tB 0.02
EV/EBITDA 21.52
EPS(TTM)-1.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1036.14
FCFYN/A
OCF(TTM)44.29
OCFY285.12%
SpS1075.95
BVpS1183.83
TBVpS910.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.4%
ROE -4.49%
ROCE 2.65%
ROIC 2.1%
ROICexc 2.1%
ROICexgc 2.15%
OM 26.32%
PM (TTM) N/A
GM 54.29%
FCFM N/A
ROA(3y)-0.29%
ROA(5y)-0.3%
ROE(3y)-3.87%
ROE(5y)-3.15%
ROIC(3y)3.23%
ROIC(5y)3.15%
ROICexc(3y)3.36%
ROICexc(5y)3.27%
ROICexgc(3y)3.45%
ROICexgc(5y)3.36%
ROCE(3y)4.09%
ROCE(5y)3.99%
ROICexcg growth 3Y-3.47%
ROICexcg growth 5Y2.52%
ROICexc growth 3Y-3.3%
ROICexc growth 5Y2.51%
OM growth 3Y-4.33%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.18%
GM growth 5Y-4.52%
F-Score4
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 3.95
Debt/FCF N/A
Debt/EBITDA 14.34
Cap/Depr 2516.46%
Cap/Sales 100.42%
Interest Coverage 0.56
Cash Conversion 13.58%
Profit Quality N/A
Current Ratio 0.2
Quick Ratio 0.19
Altman-Z N/A
F-Score4
WACC5.52%
ROIC/WACC0.38
Cap/Depr(3y)1344.37%
Cap/Depr(5y)1108.74%
Cap/Sales(3y)60.6%
Cap/Sales(5y)50.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.01%
Revenue growth 3Y8.67%
Revenue growth 5Y2.12%
Sales Q2Q%-25.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-40.06%
EBIT growth 3Y3.96%
EBIT growth 5Y-1.64%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-52.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y125.35%
OCF growth 3Y17.7%
OCF growth 5Y9.63%